A multicenter randomized phase III study for newly diagnosed, maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide versus chemoradiotherapy alone: Japan Clinical Oncology Group study JCOG1703 (MACS study).Ryuta Saito, Yoshitaka Narita, Junki Mizusawa et al.|Journal of Clinical Oncology|2026Cited by 0